538
Views
24
CrossRef citations to date
0
Altmetric
Research Articles

The Validity of Reporting Willingness to Use a Supervised Injecting Facility on Subsequent Program Use among People Who Use Injection Drugs

, PhD, , PhD, , MSc, , MD, , MD, DSc (hon), FRCPC, FCCP, FACP, FRSC, OBC & , M.D., Ph.D.
Pages 55-62 | Published online: 11 Aug 2011

REFERENCES

  • DeBeck K, Wood E, Montaner J, Kerr T. Canada’s 2003 renewed drug strategy – An evidence-based review. HIV AIDS Policy Law Rev 2006; 11(2–3): 1, 5–12.
  • Reuter P, Caulkins J. Redefining the goals of national drug policy: Recommendations from a working group. Am J Public Health 1995; 85(8 Pt 1):1059.
  • Rhodes T. The ‘risk environment’: A framework for understanding and reducing drug-related harm. Int J Drug Policy 2002; 13(2):85–94.
  • Wood E, Stoltz JA, Zhang R, Strathdee SA, Montaner JSG, Kerr T. Circumstances of first crystal methamphetamine use and initiation of injection drug use among high-risk youth. Drug Alcohol Rev 2008; 27(3):270–276.
  • Rowden D, Dorsey P, Bullman S, Lestina R, Han C, Herrell J. HIV outreach for hard-to-reach populations: A cross-site perspective. Eval Program Plann 1999; 22(3):251–258.
  • Vlahov D, Coady MH, Ompad DC, Galea S. Strategies for improving influenza immunization rates among hard-to-reach populations. J Urban Health 2007; 84(4):615–631.
  • Platt L, Wall M, Rhodes T, Judd A, Hickman M, Johnston LG, Renton A, Bobrova N, Sarang A. Methods to recruit hard-to-reach groups: Comparing two chain referral sampling methods of recruiting injecting drug users across nine studies in Russia and Estonia. J Urban Health 2006; 83(6 Suppl.):i39–i53.
  • Wood E, Kerr T, Montaner J, Strathdee S, Wodak A, Hankins C, Schechter M, Tyndall M. Rationale for evaluating North America’s first medically supervised safer-injecting facility. Lancet Infect Dis 2004; 4(5):301–306.
  • McCoy CB, Metsch LR, Chitwood DD, Miles C. Drug use and barriers to use of health care services. Subst Use Misuse 2001; 36(6):789–804.
  • Strathdee SA, Palepu A, Cornelisse PGA, Yip B, O‘Shaughnessy MV, Montaner JSG, Schechter M, Hogg R. Barriers to use of free antiretroviral therapy in injection drug users. J Am Med Assoc 1998; 280(6):547.
  • Edlin BR, Kresina TF, Raymond DB, Carden MR, Gourevitch MN, Rich JD, Cheever L, Cargill V. Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users. Clin Infect Dis 2005; 40(Suppl. 5):S276–S285.
  • Wood E, Kerr T, Spittal PM, Li K, Small W, Tyndall MW, Hogg R, O’Shaughnessy M. The potential public health and community impacts of safer injecting facilities: Evidence from a cohort of injection drug users. JAIDS 2003; 32(1Money Management in Substance Abusers (Guest Editor: Marc Rosen)):2.
  • Wood E, Tyndall M, Montaner J, Kerr T. Summary of findings from the evaluation of a pilot medically supervised safer injecting facility. CMAJ 2006; 175(11):1399–1404.
  • Coyne-Beasley T, Ford CA, Waller MW, Adimora AA, Resnick MD. Sexually active students’ willingness to use school-based health centers for reproductive health care services in North Carolina. Ambul Pediatr 2003; 3(4):196–202.
  • Myklestad I, Rise J. Predicting willingness to engage in unsafe sex and intention to perform sexual protective behaviors among adolescents. Health Educ Behav 2007; 34(4):686–699.
  • Gibbons FX, Gerrard M, Blanton H, Russell DW. Reasoned action and social reaction: Willingness and intention as independent predictors of health risk. J Pers Soc Psychol 1998; 74(5):1164–1180.
  • Litchfield R, White K. Young adults’ willingness and intentions to use amphetamines: An application of the theory of reasoned action. E J Appl Psychol 2006; 2(1Money Management in Substance Abusers (Guest Editor: Marc Rosen)):45–51.
  • Gerrard M, Gibbons FX, Stock ML, Lune LS, Cleveland MJ. Images of smokers and willingness to smoke among African American pre-adolescents: An application of the prototype/willingness model of adolescent health risk behavior to smoking initiation. J Pediatr Psychol 2005; 30(4):305–318.
  • Gibbons FX, Gerrard M, Lane DJ. A social reaction model of adolescent health risk. In Social Psychological Foundations of Health and Illness. Suls JM, Wallston KA, eds. Oxford: Blackwell, 2003; 107.
  • Kerr T, Wood E, Small D, Palepu A, Tyndall MW. Potential use of safer injecting facilities among injection drug users in Vancouver’s Downtown Eastside. CMAJ 2003; 169(8):759.
  • Kral AH, Wenger L, Carpenter L, Wood E, Kerr T, Bourgois P. Acceptability of a safer injection facility among injection drug users in San Francisco. Drug Alcohol Depend 2010; 110(1–2):160–163.
  • Hunt N, Lloyd C, Kimber J, Tompkins C. Public injecting and willingness to use a drug consumption room among needle exchange programme attendees in the UK. Int J Drug Policy 2007; 18(1Money Management in Substance Abusers (Guest Editor: Marc Rosen)):62–65.
  • O’Shea M. Introducing safer injecting facilities (SIFs) in the Republic of Ireland: ‘Chipping away’ at policy change. Drugs Educ Prev Policy 2007; 14(1Money Management in Substance Abusers (Guest Editor: Marc Rosen)):75–88.
  • Fry CL. Injecting drug user attitudes towards rules for supervised injecting rooms: Implications for uptake. Int J Drug Policy 2002; 13(6):471–476.
  • Fry C, Fox S, Rumbold G. Establishing safe injecting rooms in Australia: Attitudes of injecting drug users. Aust N Z J Public Health 2008; 23(5):501–504.
  • Van Beek I, Gilmour S. Preference to have used a medically supervised injecting centre among injecting drug users in Kings Cross, Sydney. Aust N Z J Public Health 2000; 24(5):540–542.
  • Wood E, Tyndall MW, Spittal PM, Li K, Kerr T, Hogg RS, Montaner J, O’Shaughnessy M, Schechter M. Unsafe injection practices in a cohort of injection drug users in Vancouver: Could safer injecting rooms help? CMAJ 2001; 165(4):405–410.
  • Kerr T, Marshall A, Walsh J, Palepu A, Tyndall M, Montaner J, Hogg R, Wood E. Determinants of HAART discontinuation among injection drug users. AIDS Care 2005; 17(5):539–549.
  • Tyndall M, Kerr T, Zhang R, King E, Montaner J, Wood E. Attendance drug use patterns, and referrals made from North America’s first supervised injection facility. Drug Alcohol Depend 2006; 83(3):193–198.
  • Maldonado G, Greenland S. Simulation study of confounder-selection strategies. Am J Epidemiol 1993; 138(11):923–936.
  • Rothman KJ, Greenland S. Modern Epidemiology. New York: Lippincott Williams & Wilkins, 1998.
  • Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986; 73(1Money Management in Substance Abusers (Guest Editor: Marc Rosen)):13.
  • Armitage CJ, Conner M. Efficacy of the theory of planned behaviour: A meta-analytic review. Br J Soc Psychol 2001; 40(Pt 4):471–499.
  • Hukkelberg SS, Dykstra JL. Using the prototype/willingness model to predict smoking behaviour among Norwegian adolescents. Addict Behav 2009; 34(3):270–276.
  • Albarracin D, Johnson BT, Fishbein M, Muellerleile PA. Theories of reasoned action and planned behavior as models of condom use: A meta-analysis. Psychol Bull 2001; 127(1Money Management in Substance Abusers (Guest Editor: Marc Rosen)):142–161.
  • Sheeran P, Orbell S. Do intentions predict condom use? Meta-analysis and examination of six moderator variables. Br J Soc Psychol 1998; 37(Pt 2):231–250.
  • Fisher WA, Fisher JD, Rye BJ. Understanding and promoting AIDS-preventive behavior: Insights from the theory of reasoned action. Health Psychol 1995; 14(3):255–264.
  • Wood E, Tyndall M, Li K, Lloyd-Smith E, Small W, Montaner J, Kerr T. Do supervised injecting facilities attract higher-risk injection drug users? Am J Prev Med 2005; 29(2):126–130.
  • Petrar S, Kerr T, Tyndall MW, Zhang R, Montaner JS, Wood E. Injection drug users’ perceptions regarding use of a medically supervised safer injecting facility. Addict Behav 2007; 32(5):1088–1093.
  • Fast D, Shoveller J, Shannon K, Kerr T. Safety and danger in downtown Vancouver: Understandings of place among young people entrenched in an urban drug scene. Health Place 2010; 16(1Money Management in Substance Abusers (Guest Editor: Marc Rosen)):51–60.
  • Jürgens R. Nothing about Us without Us: Greater, Meaningful Involvement of People Who Use Illegal Drugs: A Public Health, Ethical and Human Rights Imperative. Toronto, ON, Canada: Canadian HIV/AIDS Legal Network, 2005.
  • Wood E, Kerr T, Lloyd-Smith E, Buchner C, Marsh D, Montaner J, Tyndall M. Methodology for evaluating Insite: Canada’s first medically supervised safer injection facility for injection drug users. Harm Reduct J 2004; 1(9):1–5.
  • Tyndall MW, Craib KJP, Currie S, Li K, O’Shaughnessy MV, Schechter MT. Impact of HIV infection on mortality in a cohort of injection drug users. JAIDS 2001; 28(4):351.
  • DeBeck K, Kerr T, Li K, Fischer B, Buxton J, Montaner J, Wood E. Emergence of crack cocaine smoking as a risk factor for HIV seroconversion among injection drug users in Vancouver, Canada. CMAJ 2009; 181(9):585–589.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.